Enlivex Successfully Completes First Trial for Treatment of Graft-Versus-Host Disease (GVHD)
Enlivex – a Hadasit start-up company (under HBL) which develops a preventive immune-modulatory treatment invented by Prof. Dror Mevorach and his laboratory at Hadassah Medical Center – has successfully completed…
